1. Home
  2. VCYT vs SXI Comparison

VCYT vs SXI Comparison

Compare VCYT & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • SXI
  • Stock Information
  • Founded
  • VCYT 2006
  • SXI 1955
  • Country
  • VCYT United States
  • SXI United States
  • Employees
  • VCYT N/A
  • SXI N/A
  • Industry
  • VCYT Medical Specialities
  • SXI Industrial Machinery/Components
  • Sector
  • VCYT Health Care
  • SXI Industrials
  • Exchange
  • VCYT Nasdaq
  • SXI Nasdaq
  • Market Cap
  • VCYT 2.4B
  • SXI 2.4B
  • IPO Year
  • VCYT 2013
  • SXI N/A
  • Fundamental
  • Price
  • VCYT $31.83
  • SXI $204.47
  • Analyst Decision
  • VCYT Buy
  • SXI Strong Buy
  • Analyst Count
  • VCYT 9
  • SXI 4
  • Target Price
  • VCYT $39.89
  • SXI $223.50
  • AVG Volume (30 Days)
  • VCYT 921.3K
  • SXI 86.0K
  • Earning Date
  • VCYT 11-05-2025
  • SXI 10-28-2025
  • Dividend Yield
  • VCYT N/A
  • SXI 0.61%
  • EPS Growth
  • VCYT N/A
  • SXI N/A
  • EPS
  • VCYT 0.34
  • SXI 4.64
  • Revenue
  • VCYT $479,129,000.00
  • SXI $790,107,000.00
  • Revenue This Year
  • VCYT $14.19
  • SXI $14.61
  • Revenue Next Year
  • VCYT $9.68
  • SXI $7.59
  • P/E Ratio
  • VCYT $95.21
  • SXI $45.23
  • Revenue Growth
  • VCYT 19.91
  • SXI 9.64
  • 52 Week Low
  • VCYT $22.61
  • SXI $128.85
  • 52 Week High
  • VCYT $47.32
  • SXI $212.66
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 58.59
  • SXI 53.85
  • Support Level
  • VCYT $30.67
  • SXI $197.66
  • Resistance Level
  • VCYT $32.34
  • SXI $209.36
  • Average True Range (ATR)
  • VCYT 1.18
  • SXI 5.49
  • MACD
  • VCYT -0.06
  • SXI -1.19
  • Stochastic Oscillator
  • VCYT 73.71
  • SXI 50.64

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. The company has five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The maximum revenue is generated from its Electronics segment, which is a component and value-added services provider of both sensing and switching technologies, as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging, among others. Geographically, it derives key revenue from the United States and the rest from the Asia Pacific, Europe, the Middle East, and Africa (EMEA), as well as other regions.

Share on Social Networks: